Inovio shares soar again on NIH vax research pact

Shares of Inovio Biomedical jumped again on Monday after the San Diego-based biotech company announced a pact with the NIH Vaccine Research Center to explore new universal influenza jabs and speed development of swine flu vaccines. Story

Suggested Articles

Pliant Therapeutics will use the proceeds to push its lead program through midstage trials in fibrotic liver and lung diseases.

Cancer biotech Novellus has struck a deal with Plexxikon for its early- to midstage BRAF-inhibiting hopeful PLX8394.

Chinook Therapeutics is set to merge with fallen Big Pharma darling Aduro Biotech to create a kidney disease player with $180 million in cash.